These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29016743)

  • 1. Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.
    Wu JH; Li Y; Zhou YF; Haslam J; Elvis ON; Mao L; Xia YP; Hu B
    Cardiovasc Res; 2017 Dec; 113(14):1763-1775. PubMed ID: 29016743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT4 regulated neointimal formation in injured mouse arteries by matrix metalloproteinase 2-mediated smooth muscle cells proliferation and migration.
    Ding X; Yan Y; Zhang C; Xu X; Yang F; Liu Y; Wang G; Qin Y
    J Cell Physiol; 2021 Jul; 236(7):5421-5431. PubMed ID: 33372301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
    Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
    J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galangin inhibits neointima formation induced by vascular injury
    Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X
    Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
    Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
    Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
    Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
    PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation.
    Zhu N; Xiang Y; Zhao X; Cai C; Chen H; Jiang W; Wang Y; Zeng C
    J Cell Mol Med; 2019 Dec; 23(12):8482-8492. PubMed ID: 31638340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.
    Zhang C; Chen D; Maguire EM; He S; Chen J; An W; Yang M; Afzal TA; Luong LA; Zhang L; Lei H; Wu Q; Xiao Q
    Cardiovasc Res; 2018 Mar; 114(3):443-455. PubMed ID: 29206900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MAD2B alleviates venous neointimal formation by suppressing VSMCs proliferation and migration.
    Song AN; Yin XJ; Gao P; Tang H; Meng XF; Zhang C
    FASEB J; 2021 Nov; 35(11):e21959. PubMed ID: 34605572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
    Shao W; Li X; Peng J; Fan S; Liang M; Huang K
    J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
    Guan S; Tang Q; Liu W; Zhu R; Li B
    Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway.
    Jiang A; Liu L; Wang J; Liu Y; Deng S; Jiang T
    Cardiovasc Toxicol; 2024 Jun; 24(6):587-597. PubMed ID: 38691303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
    Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
    Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
    Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
    Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF13 promotes VSMCs phenotypic dedifferentiation by directly binding to the SM22α promoter.
    Yuan X; Jiang C; Xue Y; Guo F; Luo M; Guo L; Gao Y; Yuan T; Xu H; Chen H
    J Cell Physiol; 2024 May; 239(5):e31251. PubMed ID: 38634445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.